Related references
Note: Only part of the references are listed.Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients
Lene Meldgaard Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration
Evangelos Terpos et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors
Meletios A. Dimopoulos et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Staging of chronic kidney disease: Time for a course correction
Carolyn Bauer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study
J. F. San-Miguel et al.
LEUKEMIA (2008)
Pathogenesis and treatment of renal failure in multiple myeloma
M. A. Dimopoulos et al.
LEUKEMIA (2008)
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens
Maria Roussou et al.
LEUKEMIA & LYMPHOMA (2008)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Multiple myeloma presenting with advanced renal failure: A case report and new treatment options
S. Pierson Gladney et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Pegylated Liposomal Doxorubicin plus Bortezomib in Relapsed or Refractory Multiple Myeloma: Efficacy and Safety in Patients with Renal Function Impairment
Joan Blade et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
HLA-identical sibling stem-cell transplantation in first-remission AML
Silkander Ailawadhi et al.
BLOOD (2007)
Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis
Nionhang Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
Heinz Ludwig et al.
HAEMATOLOGICA (2007)
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents
Efstathios Kastritis et al.
HAEMATOLOGICA (2007)
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A. Chanan-Khan et al.
BLOOD (2007)
Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance
V. Eleutherakis-Papaiakovou et al.
LEUKEMIA & LYMPHOMA (2007)
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib
Paul G. Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function
Radovan Hojs et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Bortezomib and dexamethasone in previously untreated multiple myeloma associated with renal failure and reversal of renal failure
Ashok Kumar Malani et al.
ACTA HAEMATOLOGICA (2006)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bortezornib in recurrent and/or refractory multiple myeloma - Initial clinical experience in patients with impaired renal function
S Jagannath et al.
CANCER (2005)
Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure - a retrospective analysis and recommendations for dose adjustment
K Carlson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
AS Levey et al.
ANNALS OF INTERNAL MEDICINE (2003)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Renal failure in multiple myeloma: reversibility and impact on the prognosis
LM Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Renal involvement in multiple myeloma: A 10-year study
V Sakhuja et al.
RENAL FAILURE (2000)
Share Paper
